echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Front Oncol: Li Qi's team study the efficacy of Chinese medicine formula PRM1201 combined with chemotherapy in adjuvant treatment of stage III colon cancer patients: a randomized, double-blind, placebo-controlled study

    Front Oncol: Li Qi's team study the efficacy of Chinese medicine formula PRM1201 combined with chemotherapy in adjuvant treatment of stage III colon cancer patients: a randomized, double-blind, placebo-controlled study

    • Last Update: 2021-10-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    PRM1201 is a traditional Chinese medicine formula composed of 7 Chinese herbal medicines


    Colorectal cancer

    In this study, patients with stage III colon cancer who underwent radical surgical resection were randomly divided into adjuvant chemotherapy (FOLFOX q2w for 6 months, or CapeOx q3w for 6 months) + PRM1201 (chemotherapy + PRM1201 group) or adjuvant chemotherapy + placebo (Chemotherapy + placebo group)


    Colon cancer

    From January 2016 to June 2016, 420 patients from 7 medical centers were screened and 370 patients were included in the study


    Screening

    The 1-year, 2-year, and 3-year DFS rates in the chemotherapy+PRM1201 group were 91.


    The 1-year, 2-year, and 3-year DFS rates in the chemotherapy+PRM1201 group were 91.



    DFS




    Adverse events

    In summary, studies have shown that the addition of Chinese medicine formula PRM1201 can improve the effect of adjuvant treatment of colon cancer, and can become an effective choice in clinical practice


    Studies have shown that the addition of Chinese medicine formula PRM1201 can improve the adjuvant treatment effect of colon cancer, and can become an effective choice in clinical practice


    Jia R, Liu N, Cai G, et al (2021) Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.


    Jia R, Liu N, Cai G, et al (2021) Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Front.
    Oncol.
    11 :618793.
    doi: 10.
    3389/fonc.
    2021.
    618793

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.